BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17504688)

  • 1. [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing].
    Gadea I; Cuenca-Estrella M; Martín E; Pemán J; Pontón J; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2007 May; 25(5):336-40. PubMed ID: 17504688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal infections: a survey of laboratory services for diagnosis and treatment.
    Barnes RA; Denning DW; Evans EG; Hay RJ; Kibbler CC; Prentice AG; Richardson MD; Roberts MM; Rogers TR; Speller DC; Warnock DW; Warren RE
    Commun Dis Rep CDR Rev; 1996 Apr; 6(5):R69-75. PubMed ID: 8935421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture-Based Techniques.
    Willinger B
    Methods Mol Biol; 2017; 1508():195-207. PubMed ID: 27837505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of antifungal susceptibility: Review of literature.
    Hadrich I; Ayadi A
    J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
    Kanafani ZA; Perfect JR
    Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
    Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
    Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular diagnosis of parasitic and fungal infections].
    Borrás Salvador R; Cuenca-Estrella M; Domínguez Márquez MV; Gadea Gironés I
    Enferm Infecc Microbiol Clin; 2008 Jul; 26 Suppl 9():50-7. PubMed ID: 19195447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular techniques in mycology].
    Rodríguez-Tudela JL; Cuesta I; Gómez-López A; Alastruey-Izquierdo A; Bernal-Martínez L; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():47-53. PubMed ID: 19100167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.
    Groll AH; Kolve H
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):256-70. PubMed ID: 15015031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in antifungal susceptibility testing.
    Johnson EM
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i13-8. PubMed ID: 18063599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of antifungal susceptibility testing.
    Eschenauer GA; Carver PL
    Pharmacotherapy; 2013 May; 33(5):465-75. PubMed ID: 23553342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
    Metin DY; Hilmioglu-Polat S; Hakim F; Inci R; Tumbay E
    J Chemother; 2005 Aug; 17(4):404-8. PubMed ID: 16167520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antifungal susceptibility testing in patient management.
    Forrest G
    Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infections: guidelines for reporting. PHLS Mycology Committee.
    Evans EG; Farrell ID; Gross RJ; Hay RJ; Midgley G; Reuther JW; Richardson MD; Roberts DT; Warnock DW; Warren RE; Wingfield HJ
    Commun Dis Rep CDR Rev; 1996 Apr; 6(5):R75. PubMed ID: 8935422
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal Resistance: An Emerging Reality and A Global Challenge.
    Kontoyiannis DP
    J Infect Dis; 2017 Aug; 216(suppl_3):S431-S435. PubMed ID: 28911044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for fungal diagnoses and antifungal sensitivity studies].
    Gadea I; Cuenca-Estrella M; ; ;
    Enferm Infecc Microbiol Clin; 2004 Jan; 22(1):32-9. PubMed ID: 14757006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.